The antibody experts at arGEN-X have teamed up with dermatology-focused biotech Leo Pharma on a treatment for inflammatory skin diseases, inking a deal worth up to $116 million. Under the ...

Firm received almost $2 million to support the new subsidiary. Antibody therapeutics company arGEN-X opened an R&D subsidiary in the Flanders region of Belgium. The new center of excellence will ...